Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-9/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NIH National Eye Institute. 1/1/2018-9/1/2028.
  • The Role of the Bed Nucleus of the Stria Terminalis-Norepinephrine System in Amphetamine-type Stimulant Use Disorders. Jinwoo Park (Principal Investigator). NIH/NIDA. $3,225,662. 9/1/2023-6/1/2028.
  • Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,311,139. 8/1/2023-4/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator). NIH National Eye Institute. $3,944,767. 2/1/2018-1/1/2028.
  • Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells. Zhen Yan (Principal Investigator). NINDS/NIH. $3,088,565. 2/1/2023-1/1/2028.
  • A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
  • Exercise Reset for Concussion - Modifying the Buffalo Concussion Protocol for Application in a Military Environment. John Leddy (Principal Investigator). Department of Defense (CDMRP). 1/1/2023-12/1/2027.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Transcriptomic and Circuitry Aberrations in Alzheimer’s Disease. Zhen Yan (Principal Investigator). NIA/NIH. $3,710,395. 12/1/2022-11/1/2027.
  • Injuries of the corneal endothelium. Sangita Patel (Principal Investigator). Department of Veterans Affairs, Biomedical Laboratory Research and Development. $543,160. 10/1/2023-9/1/2027.
  • “Injuries of the Corneal Endothelium”. Steven Fliesler (Co-Investigator). VA. $543,160. 10/1/2023-9/1/2027.
  • Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling. Roh-Yu Shen (Principal Investigator). NIAAA. 9/1/2022-8/1/2027.
  • Role of microglia in prenatal ethanol exposure-induced impairment of endocannabinoid signaling. Samir Haj-Dahmane (Co-Investigator). NIH. $1,813,263. 9/1/2022-6/1/2027.
  • Protist Oxygen Sensing in Human Disease. Ira Blader (Co-Principal Investigator). NIH/NIAID. $3,190,179. 7/1/2022-6/1/2027.
  • The role of the nociceptor endocytosis in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders & Stroke. $1,907,471. 6/1/2022-5/1/2027.
  • Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics. John Sullivan (Principal Investigator). NIH/NEI Scored 11% (Impact 28) on first submission. $2,239,262. 8/1/2023-3/1/2027.
  • Chromatin architectural factor-mediated epigenetic regulation of neuronal remodeling during development. Dahong Chen (Principal Investigator). NIH. $746,979. 1/1/2024-1/1/2027.
  • Effects of mesolimbic amylin signaling on macronutrient intake. Jinwoo Park (Co-Investigator). NIH/NIDDK. $1,853,714. 12/1/2021-11/1/2026.